Cargando…

Targeting MITF in the tolerance-phase

Detalles Bibliográficos
Autores principales:	Arozarena, Imanol, Smith, Michael P., Wellbrock, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342328/ https://www.ncbi.nlm.nih.gov/pubmed/27528022 http://dx.doi.org/10.18632/oncotarget.9423

Ejemplares similares

Glucose availability controls ATF4-mediated MITF suppression to drive melanoma cell growth
por: Ferguson, Jennifer, et al.
Publicado: (2017)

Microphthalmia‐associated transcription factor in melanoma development and MAP‐kinase pathway targeted therapy
por: Wellbrock, Claudia, et al.
Publicado: (2015)

The Complexity of the ERK/MAP-Kinase Pathway and the Treatment of Melanoma Skin Cancer
por: Wellbrock, Claudia, et al.
Publicado: (2016)

Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion
por: Ferguson, Jennifer, et al.
Publicado: (2012)

Effect of SMURF2 Targeting on Susceptibility to MEK Inhibitors in Melanoma
por: Smith, Michael P., et al.
Publicado: (2013)

A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITF(high)/AXL(low) melanoma
por: Smith, Michael P., et al.
Publicado: (2018)

Elevated expression of MITF counteracts B-RAF–stimulated melanocyte and melanoma cell proliferation
por: Wellbrock, Claudia, et al.
Publicado: (2005)

In melanoma, beta-catenin acts as suppressor of invasion through a cell-type specific mechanism
por: Arozarena, Imanol, et al.
Publicado: (2011)

Differential chemosensitivity to antifolate drugs between RAS and BRAF melanoma cells
por: Arozarena, Imanol, et al.
Publicado: (2014)

Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy
por: Smith, Michael P., et al.
Publicado: (2016)

Oncogenic BRAF Regulates Melanoma Proliferation through the Lineage Specific Factor MITF
por: Wellbrock, Claudia, et al.
Publicado: (2008)

An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition
por: Young, Helen L., et al.
Publicado: (2017)

Tyrosine Kinase Inhibitors in Adult Glioblastoma: An (Un)Closed Chapter?
por: Aldaz, Paula, et al.
Publicado: (2021)

The MITF regulatory network in melanoma
por: Chauhan, Jagat S., et al.
Publicado: (2022)

Acetylation reprograms MITF target selectivity and residence time
por: Louphrasitthiphol, Pakavarin, et al.
Publicado: (2023)

Partial Rescue of Ocular Pigment Cells and Structure by Inducible Ectopic Expression of Mitf-M in MITF-Deficient Mice
por: Michael, Helen T., et al.
Publicado: (2018)

MITF links maturation and quiescence
por: LeBrasseur, Nicole
Publicado: (2005)

MITF—the first 25 years
por: Goding, Colin R., et al.
Publicado: (2019)

Cooperative behaviour and phenotype plasticity evolve during melanoma progression
por: Rowling, Emily J., et al.
Publicado: (2020)

Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure
por: Smith, Michael P, et al.
Publicado: (2017)

Subcellular localization of Mitf in monocytic cells
por: Lu, Ssu-Yi, et al.
Publicado: (2010)

Mitf Induction by RANKL Is Critical for Osteoclastogenesis
por: Lu, Ssu-Yi, et al.
Publicado: (2010)

Parthenolide induces MITF-M downregulation and senescence in patient-derived MITF-M(high) melanoma cell populations
por: Hartman, Mariusz L., et al.
Publicado: (2016)

A Conditional Zebrafish MITF Mutation Reveals MITF Levels Are Critical for Melanoma Promotion vs. Regression In Vivo
por: Lister, James A, et al.
Publicado: (2014)

Novel Insights into the Role of the Mineralocorticoid Receptor in Human Glioblastoma
por: Aldaz, Paula, et al.
Publicado: (2021)

Differential Evolution of Duplicated Medakafish mitf Genes
por: Li, Mingyou, et al.
Publicado: (2013)

Meningeal Melanocytes in the Mouse: Distribution and Dependence on Mitf
por: Gudjohnsen, Stefán A. H., et al.
Publicado: (2015)

MITF and TFEB cross-regulation in melanoma cells
por: Ballesteros-Álvarez, Josué, et al.
Publicado: (2020)

Endolysosomal Cation Channels and MITF in Melanocytes and Melanoma
por: Abrahamian, Carla, et al.
Publicado: (2021)

MITF Modulates Therapeutic Resistance through EGFR Signaling
por: Ji, Zhenyu, et al.
Publicado: (2015)

Molecular Targeting of HuR Oncoprotein Suppresses MITF and Induces Apoptosis in Melanoma Cells
por: Ahmed, Rebaz, et al.
Publicado: (2021)

MiR-182 Is Upregulated in Prostate Cancer and Contributes to Tumor Progression by Targeting MITF
por: Stafford, M. Y. Cynthia, et al.
Publicado: (2023)

SOX5 is involved in balanced MITF regulation in human melanoma cells
por: Kordaß, Theresa, et al.
Publicado: (2016)

Spatial intra-tumour heterogeneity in acquired resistance to targeted therapy complicates the use of PDX models for co-clinical cancer studies
por: Wellbrock, Claudia
Publicado: (2015)

SOX10-MITF pathway activity in melanoma cells
por: Tudrej, Karol B, et al.
Publicado: (2016)

miR-148 Regulates Mitf in Melanoma Cells
por: Haflidadóttir, Benedikta S., et al.
Publicado: (2010)

MITF in melanoma: mechanisms behind its expression and activity
por: Hartman, Mariusz L., et al.
Publicado: (2014)

MITF – A controls branching morphogenesis and nephron endowment
por: Phelep, Aurélie, et al.
Publicado: (2017)

MITF induces escape from innate immunity in melanoma
por: Sánchez-del-Campo, Luis, et al.
Publicado: (2021)

Deubiquitination of MITF-M Regulates Melanocytes Proliferation and Apoptosis
por: Hu, Shuaishuai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sr999mtpsebib3t5ih75mm77sv